Mirae Asset Sharekhan

DOWNLOAD SHAREKHAN APP

Mirae Asset Sharekhan

OPEN DEMAT ACCOUNT

LOGIN / TRADE OPEN ACCOUNT

Follow Us :

Sharekhan

BUY NOW Buy Vivanza Biosciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Overview
Market Data
Market Depth
Option Chain
News
Fundamental
Shareholding Pattern
Corporate Action
Peers
Company Info
FAQ’s

Home Stock Vivanza Biosciences Ltd

Mon 15/12/2025,16:1:0

NSE

BSE

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 2.13

Previous Close

₹ 2.04

Volume

74747

Mkt Cap ( Rs. Cr)

₹8.36

High

₹ 2.13

Low

₹ 2.06

52 Week High

₹ 4.01

52 Week Low

₹ 1.90

Book Value Per Share

₹ 1.23

Dividend Yield

0.00

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Vivanza Biosciences Ltd

Your Vote -

Buy

50.00%

Hold

25.00%

Sell

25.00%

50.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Vivanza Biosciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

Vivanza Biosciences - Reg. 34 (1) Annual Report.

4 Dec 2025, 4:38PM This is to inform that, pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation of o
Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

14 Nov 2025, 3:48PM Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby submit the postal ballot notice for seeking Members' approval for the alteration
Vivanza Biosciences - Results - Financial Results For 30Th September, 2025

14 Nov 2025, 1:07PM Pursuant to regulations 30 & 33 of SEBI (LODR), we inform that the Board at its meeting held on November 11, 2025, approved:\r\n1. Un-audited & Standa
Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

27 Sep 2025, 10:20AM Dear Sir, In compliance with Regulation 44(3) of the SEBI (LODR) Regulations, 2015, we now attach herewith in the prescribed format, the details regar
Vivanza Biosciences Q2 net profit zooms 4500.00% at Rs 0.46 cr

12 Nov 2025, 2:22PM The company reported standalone net profit of Rs 0.46 crore for the quarter ended September 30, 2025 as compared to Rs 0.01 crore in the same period l
Vivanza Biosciences - Non-Applicability Of Disclosure Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For The Quarter

11 Nov 2025, 6:35PM Announcement regarding Non-Applicability of Related Party Transaction under Regulation 23(9) of SEBI LODR
Vivanza Biosciences - Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligatio

11 Nov 2025, 6:32PM Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015, attaching herewith Non-Applicability of Statement of deviation or variation
Vivanza Biosciences - Postal Ballot For Alteration Of The Main Object Clause Of The Memorandum Of Association Of The Company

11 Nov 2025, 5:44PM The board has approved conducting a Postal Ballot to seek members' consent for altering the main Object clause of Memorandum of Association. Members w
Vivanza Biosciences - Financial Results For The Quarter Ended 30Th September, 2025

11 Nov 2025, 5:34PM Pursuant to Regulation 30 and 33 of the SEBI (LODR) Regulations, 2015 we wish to inform that the board of directors at its meeting held tuesday 11th N
Vivanza Biosciences - Board Meeting Outcome for The Board Meeting Held On 11Th November, 2025

11 Nov 2025, 5:08PM Pursuant to Regulations 30 and 33 of the SEBI (LODR) Regulations, 2015, we wish to inform that the Board of Directors, at its meeting held on Tuesday,
Vivanza Biosciences - Board Meeting Intimation for Notice For The Meeting Of The Board Of Directors Pursuant To Regulation 29

3 Nov 2025, 11:05AM Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider
Vivanza Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

15 Oct 2025, 2:20PM As of September 2025, 20.02% is owned by Indian Promoters and 79.98% by Public. <p align=justify> Top two Promoters holding highest number of shares o
Vivanza Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

6 Oct 2025, 4:33PM We hereby enclose the Confirmation Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018, received from Purva Sha
Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Change in Directorate

6 Oct 2025, 4:22PM Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, and in compliance with the applicable provisions of the Companies Act, 2013 and the ru
Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

5 Oct 2025, 1:21PM Pursuant to Regulation 30 of SEBI LODR REGULATIONS, 2015 readwith Para A of Part A of Schedule III and SEBI Circular CIR/CFD/CMD/4/2015 dated Septembe
Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

26 Sep 2025, 6:02PM Resignation of Ms. Siddhi Shah as Company Secretary and Compliance Officer of the Company.
Vivanza Biosciences - Proceedings Of 43Rd Annual General Meeting

25 Sep 2025, 6:42PM We are attaching herewith proceedings of 43rd Annual General Meeting of the Company.
Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Outcome of AGM

25 Sep 2025, 6:37PM We are attaching herewith proceedings of 43rd Annual General Meeting of the Company.

Key fundamentals

Evaluate the intrinsic value of Vivanza Biosciences Ltd stock

Name	March-25	March-24	March-23	March-22	March-21
Assets	10.113	7.9781	10.9623	5.5128	3.5404
Liabilities	10.113	7.9781	10.9623	5.5128	3.5404
Equity	4	4	4	4	4
Gross Profit	-0.3634	0.7998	0.7212	0.049	0.1259
Net Profit	-0.6951	0.3174	0.5691	0.4636	0.0998
Cash From Operating Activities	-2.4688	1.7835	0.1607	-0.6771	-3.0778
NPM(%)	-23.62	2.2	4	5.06	1.08
Revenue	2.9428	14.4132	14.2071	9.1475	9.2233
Expenses	3.3062	13.6134	13.4859	9.0984	9.0973
ROE(%)	-14.12	6.45	11.56	9.42	2.02

Shareholding Pattern

Corporate Action

XD-Date	Dividend-Amount	Dividend-%	Dividend Yield(%GE)	Price on that day

From Year	To Year	Class of Share	Authorized Capital(Crores)	Issued Capital(Crores)	Paid Up Shares(NOS)	Paid Up Face Value	Paid Up Capital(Crores)
2024	2025	Equity Share	4.00	4.00	40000000.00	1	4.00
2023	2024	Equity Share	4.00	4.00	40000000.00	1	4.00
2022	2023	Equity Share	4.00	4.00	40000000.00	1	4.00
2021	2022	Equity Share	4.00	4.00	4000000.00	10	4.00
2020	2021	Equity Share	4.00	4.00	4000000.00	10	4.00
2019	2020	Equity Share	4.00	4.00	4000000.00	10	4.00
2018	2019	Equity Share	4.00	4.00	4000000.00	10	4.00
2017	2018	Equity Share	4.00	4.00	4000000.00	10	4.00
2016	2017	Equity Share	4.00	4.00	4000000.00	10	4.00
2015	2016	Equity Share	4.00	0.19	188000.00	10	0.19
2014	2015	Equity Share	4.00	3.76	3760000.00	10	3.76
2013	2014	Equity Share	4.00	3.76	3760000.00	10	3.76
2012	2013	Equity Share	4.00	3.76	3760000.00	10	3.76
2011	2012	Equity Share	4.00	3.76	3760000.00	10	3.76
2010	2011	Equity Share	4.00	3.76	3760000.00	10	3.76
2009	2010	Equity Share	4.00	3.76	3760000.00	10	3.76
2001	2002	Equity Share	4.00	3.76	3760000.00	10	3.76
1999	2000	Equity Share	4.00	3.76	3760000.00	10	3.76
1996	1999	Equity Share	4.00	3.76	3760000.00	10	3.76
1995	1996	Equity Share	4.00	3.76	3760000.00	10	3.76

Announcement Date	Price	Bonus Ratio	Record Date

Fund	Market Value(CR)	% Hold
No Records Found

Peers

Other companies within the same industry or sector that are comparable to Vivanza Biosciences Ltd

Company	Price	Price (% change)	pe(x)	EV/EBITDA(x)	ROE(%)	ROCE(%)
Albert David Ltd	751.25	-2.14	0.00	1.16	301.39	0.66
Lotus Eye Hospital and Institute Ltd	131.00	2.02	410.97	4.24	3.55	0.00
Bharat Immunological and Biologicals Corporation Ltd	18.94	0.26	0.00	8.81	-39.50	0.00
Astec Lifesciences Ltd	709.00	0.81	0.00	4.00	-604.77	0.00

Company Info

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Read More

Parent Organisation

Vivanza Biosciences Ltd.

Founded

06/03/1982

Managing Director

Mr.J A Mehta

NSE Symbol

FAQ

The current price of Vivanza Biosciences Ltd is ₹ 2.09.

The 52-week high for Vivanza Biosciences Ltd is

The market capitalization of Vivanza Biosciences Ltd is currently ₹ 8.36. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Vivanza Biosciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Vivanza Biosciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vivanza Biosciences Ltd shares.

The CEO of Vivanza Biosciences Ltd is Mr.J A Mehta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT